ALLMedicine™ Sinus Bradycardia Center

Jul 28th, 2021 - ► Syncopal episode ► Sinus bradycardia ► History of bipolar disorder.

Jul 22nd, 2021 - Sinus Bradycardia in Children Treated With Remdesivir for COVID-19.|2021|Eleftheriou I,Liaska M,Krepis P,Dasoula F,Dimopoulou D,|

Jul 20th, 2021 - A 70-year-old female with dextrocardia with situs inversus (DSI) totalis and inferior vena cava occlusion underwent radiofrequency catheter ablation because she had symptomatic paroxysmal atrial fibrillation (AF). Careful preoperative examination ...

Jul 4th, 2021 - To assess the clinical characteristics and clinical outcomes of bradycardic patients with coronavirus disease 2019 (COVID-19) pneumonia. The electronic medical records of 221 consecutive patients hospitalized for COVID-19 pneumonia between June an...

Jun 27th, 2021 - Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to ...

Jan 22nd, 2020 - This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced by rocuronium or vecuronium in adult ASA Physical Status Cla...

Jul 15th, 2021 - NEW YORK (Reuters Health) - Remdesivir treatment of lower respiratory infection in hospitalized patients with COVID-19 appears safe, even though some patients develop sinus bradycardia, a single-center prospective study from Italy suggests. "Cardi...

Jun 11th, 2021 - Following a safety review, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended adding sinus bradycardia to the product label for remdesivir (Veklury) as an adverse reaction of "unknown freq...

Feb 16th, 2021 - Remdesivir (Veklury) is not associated with acute kidney injury, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has concluded following a safety review. Remdesivir currently has conditional marketing ...

Jul 1st, 2019 - The correct diagnosis is sinus bradycardia, interpolated junctional premature complexes in a trigeminal pattern, and retrograde concealed conduction. Figure 2. Courtesy of Dr Podrid Discussion The rhythm is irregular, but there is a pattern. All o...

Aug 8th, 2018 - ANSWER The correct interpretation includes marked sinus bradycardia with sinus arrhythmia, biatrial enlargement, and an RSR’ pattern in lead V1 suggestive of right ventricular conduction delay. A heart rate below 60 beats/min is considered sinus b.